ISPO

Genetic Markers II

Amplification and overexpression of cyclin D1, and chromsomal abnormalities in squamous cell carcinoma of the head and neck

J Akervall MD, R Michalides PhD, H Mineta MD, Y Jin MD, J Wennerberg MD

Prognostic value of immunohistological factors in head and neck squamous cell carcinoma (HNSCC): results of a case-control study

M Guerry MD, L Vabre MD, M Talbot, A-M Leridant MD, G Mamelle MD, C Hill PhD, J Bosq MD, F Janot MD

Overexpression of p53 predicts rapid growth rate of head and neck cancer

E Cvetkovska, C Wedenberg, T Westin, S Edstrom

On the clinical role of p53 overexpression versus p53 mutation in head and neck cancer

R Erber, C Enders, M Finckh, H Weidauer, FX Bosch

Expression of retinoic acid receptor beta (RARbeta) in normal or malignant head and neck tissues: correlation between tumoral state and a decreased expression

L Castillo MD, V Pierrefite PhD, J Santini MD, G Milano PharmD

Heterogeneity of expression of cell adhesion molecules in squamous carcinomas of the head and neck

TR Helliwell MD FRCPath, AR Kinsella PhD, N Andrews BSc, M Bray BSc, AS Jones MD FRCS

Looking for a new tumour suppressor gene on 17p implicated in paediatric brain tumors

AC Orellana, M Hernandez, F Martinez, V Castell, JM Millan, J Alvarez, F Prieto, L Badia

A multiparameter approach in the prognosis of nasopharyngeal carcinoma

T Yip PhD, WH Lau FRCR, JKC Chan MRCPath, KC Ngan FRCR, YF Poon FRCR, J Ho MD DSc FRCP FRCR

Cyclin D1 gene amplification and expression in laryngeal squamous cell carcinomas

P Capaccio, G Pruneri, NS Fracchiolla, N Carboni, R Buffa, A Neri, L Pignataro

P53 gene alterations and p53 protein expression in laryngeal squamous cell carcinomas

L Pignataro, G Pruneri, NS Fracchiolla, P Capaccio, N Carboni, A Boletini, R Buffa, A Neri

Differences between invasive squamous cell carcinoma (SCCA) and verrucous carcinoma (VC) of the oral cavity: expression of bcl-2, p53, Her-2/neu and indexes of cell turnover

CB Drachenberg MD, RA Ord MD, J Simons HT, JC Papadimitriou MD PhD

E-cadherin mutations as basis for diagnostic and therapy of diffuse type gastric cancer

C Schuhmacher MD, K-F Becker PhD, I Becker MD, G Handschuh, E Kremmer MD, M Eulitz MD, H Hoefler MD

Immunohistochemical detection of p53 protein in transitional cell carcinoma of the bladder in correlation to DNA ploidy and pathohistological stage and grade

H Al-Abadi MD, R Nagel MD, P Neuhaus MD

Use of molecular alterations for the prognosis of urothelial carcinoma

WA Schulz, BJ Schmitz-Drager

Microsatellite analysis for detection of multiple suppressor gene abnormalities on primary human bladder cancers

A Miyakawa MD, N Tachibana MD, A Uchida MD, K Nakamura, M Murai MD

Microsatellite instability in biadder tumors from patients below age 55

M Christensen , IL Thorsen , H Wolf MD , TF Orntoft

Standardized agnor analysis in colorectal adenocarcinoma: correlation with chemotherapy efficiency

D Ofner, H Weiss, P Sandbichler, H Maier, P Larcher, P Holzberger, M Totsch, K W Schmid